Candace L Haddox

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Leukemia & lymphoma

CA: a cancer journal for clinicians

Expert review of anticancer therapy

National Institutes of Health

University of Miami (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Institutes of Health Jul 05 2009 - Jul 22 2011

United States

Post-baccalaureate Intramural Research Training Award Fellow :: NIDCR- Matrix and Morphogenesis Unit

University of Miami Jun 01 2008 - Jun 01 2009

United States

Research Associate :: Miami Project to Cure Paralysis

Education History

University of Miami Aug 01 2004 - May 01 2008

United States

BSC :: Neuroscience

Publications

Candace L Haddox, Michael J Nathenson, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska, Allison N Nau, Jason L Weirather, Edwin Choy, Adrian Mariño-Enriquez, Jeffrey A Morgan, Gregory M Cote, Priscilla A Merriam, Andrew J Wagner, Peter Karl Sorger, Sandro Santagata, Suzanne George
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft Tissue Sarcomas: Clinical Outcomes and Biological Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Candace L Haddox, Michael J Nathenson, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska, Allison N Nau, Jason L Weirather, Edwin Choy, Adrian Mariño-Enriquez, Jeffrey A Morgan, Gregory M Cote, Priscilla A Merriam, Andrew J Wagner, Peter Karl Sorger, Sandro Santagata, Suzanne George
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Gregory M Cote, Candace L Haddox, Edwin Choy, Priscilla A Merriam, Emanuele Mazzola, Vinayak Venkataraman, Thierry Alcindor, Andrew J Wagner, George D Demetri, Suzanne George
Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Candace L Haddox, Michael J Nathenson, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska, Allison N Nau, Jason L Weirather, Edwin Choy, Adrian Mariño-Enriquez, Jeffrey A Morgan, Gregory M Cote, Priscilla A Merriam, Andrew J Wagner, Peter Karl Sorger, Sandro Santagata, Suzanne George
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft Tissue Sarcomas: Clinical Outcomes and Biological Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Gregory M Cote, Candace L Haddox, Edwin Choy, Priscilla A Merriam, Emanuele Mazzola, Vinayak Venkataraman, Thierry Alcindor, Andrew J Wagner, George D Demetri, Suzanne George
Safety And Efficacy Of Combination Lurbinectedin Plus Doxorubicin From A Phase 1b Trial In Patients With Advanced/Metastatic Soft Tissue Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Candace L Haddox, Michael J Nathenson, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska, Allison N Nau, Jason L Weirather, Edwin Choy, Adrian Mariño-Enriquez, Jeffrey A Morgan, Gregory M Cote, Priscilla A Merriam, Andrew J Wagner, Peter Karl Sorger, Sandro Santagata, Suzanne George
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Lars D Engstrom, Ruth Aranda, Laura Waters, Krystal Moya, Vickie Bowcut, Laura Vegar, David Trinh, Allan Hebbert, Christopher R Smith, Svitlana Kulyk, J David Lawson, Quanyuan He, Laura D Hover, Julio Fernandez-Banet, Jill Hallin, Darin Vanderpool, David M Briere, Alice Blaj, Matthew A Marx, Jordi Rodon Ahnert, Michael D Offin, Kathryn C Arbour, Melissa Lynne Johnson, David J Kwiatkowski, Pasi A Janne, Candace L Haddox, Kyriakos P Papadopoulos, Jason T Henry, Konstantinos Leventakos, James G Christensen, Ronald Shazer, Peter Olson
MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP deleted cancer. Cancer discovery (2023)
Candace L Haddox, Elizabeth H Baldini, Jyothi P Jagannathan, Jason L Hornick, Chandrajit P Raut
Multidisciplinary approach for a high-risk, localized soft tissue sarcoma of the trunk after unplanned nononcological resection. CA: a cancer journal for clinicians (2023)
Candace L Haddox, Richard F Riedel
Individualizing systemic therapy for advanced soft tissue sarcomas based on tumor histology and biology. Expert review of anticancer therapy 20 (1) (2019)
Candace L Haddox, Ryan M Carr, Roshini S Abraham, Juliana Perez Botero, Vilmarie Rodriguez, Animesh Pardanani, Mirinal S Patnaik
Phenotypic heterogeneity associated with germline GATA2 haploinsufficiency: a comprehensive kindred study. Leukemia & lymphoma 60 (13) (2019)

Candace L Haddox.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Candace L Haddox